Patents by Inventor Robert D Torgerson
Robert D Torgerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220160941Abstract: Medical grade yarns, medical devices constructed of such yarns, and methods for making such yarns and devices are described. Polyester drawn fibers, and more particularly high strength and high tenacity micro polyester fibers for use in medical devices, and methods of preparing the same are provided.Type: ApplicationFiled: February 13, 2022Publication date: May 26, 2022Applicant: RxFiber, LLCInventor: Robert D. Torgerson
-
Patent number: 11285246Abstract: Medical grade yarns, medical devices constructed of such yarns, and methods for making such yarns and devices are described. Polyester drawn fibers, and more particularly high strength and high tenacity micro polyester fibers for use in medical devices, and methods of preparing the same are provided.Type: GrantFiled: September 8, 2020Date of Patent: March 29, 2022Assignee: RxFiber, LLCInventor: Robert D. Torgerson
-
Publication number: 20200405922Abstract: Medical grade yarns, medical devices constructed of such yarns, and methods for making such yarns and devices are described. Polyester drawn fibers, and more particularly high strength and high tenacity micro polyester fibers for use in medical devices, and methods of preparing the same are provided.Type: ApplicationFiled: September 8, 2020Publication date: December 31, 2020Applicant: RxFiber, LLCInventor: Robert D. Torgerson
-
Patent number: 10835645Abstract: Medical grade yarns, medical devices constructed of such yarns, and methods for making such yarns and devices are described. Polyester drawn fibers, and more particularly high strength and high tenacity micro polyester fibers for use in medical devices, and methods of preparing the same are provided.Type: GrantFiled: August 3, 2018Date of Patent: November 17, 2020Assignee: RxFiberLLCInventor: Robert D. Torgerson
-
Patent number: 6869800Abstract: An instrument comprising a housing (30) having a fluid-tight seal and a probe (10), adapted to carry a catalyst or sorbent (37), for monitoring a process fluid stream or the behavior of a catalyst or sorbent placed therein. The use of such an instrument permits investigation of catalyst or sorbent behavior in process fluid streams without the need for process shut down or construction of separate process equipment.Type: GrantFiled: January 10, 2002Date of Patent: March 22, 2005Assignee: Imperial Chemical Industries PLCInventors: Robert D Torgerson, Peter E J Abbott
-
Patent number: 6454787Abstract: A hemostatic device formed of collagen particles and methods for producing and using the hemostatic device to control bleeding are provided. The collagen particles of the hemostatic device have a hemostatic activity that is equivalent to the hemostatic activity of the collagen particles from which the hemostatic device is formed. More preferably, the hemostatic devices are formed of Avitene® flour and the collagen particles of the hemostatic devices of the invention have a hemostatic activity equivalent to the hemostatic activity of Avitene® flour. The hemostatic devices optionally include hemostatic agents and/or therapeutic agents, to further promote hemostasis and wound healing.Type: GrantFiled: December 11, 1998Date of Patent: September 24, 2002Assignee: C. R. Bard, Inc.Inventors: Francis B. Maddalo, Mark V. Iampietro, Stephen N. Eldridge, Robert D. Torgerson
-
Publication number: 20020103503Abstract: A collagen fiber and methods for producing and using the collagen fiber of the inventions to prepare hemostatic fabrics to control bleeding are provided. The collagen particles (e.g., fibrils) of the fiber, preferably, have a hemostatic activity that is equivalent to the hemostatic activity of the collagen particles from which the fiber is formed. The collagen fibers of the invention and hemostatic fabrics formed thereof optionally include hemostatic agents and/or other therapeutic agents, to further promote hemostasis and wound healing.Type: ApplicationFiled: March 1, 2002Publication date: August 1, 2002Inventors: Robert D. Torgerson, John Uhoch, Francis B. Maddalo, Stephen N. Eldridge
-
Publication number: 20020059842Abstract: An instrument comprising a housing (30) having a fluid-tight seal and a probe (10), adapted to carry a catalyst or sorbent (37), for monitoring a process fluid stream or the behavior of a catalyst or sorbent placed therein. The use of such an instrument permits investigation of catalyst or sorbent behavior in process fluid streams without the need for process shut down or construction of separate process equipment.Type: ApplicationFiled: January 10, 2002Publication date: May 23, 2002Inventors: Robert D. Torgerson, Peter E. J. Abbott
-
Patent number: 6361551Abstract: A collagen fiber and methods for producing and using the collagen fiber of the inventions to prepare hemostatic fabrics to control bleeding are provided. The collagen particles (e.g., fibrils) of the fiber, preferably, have a hemostatic activity that is equivalent to the hemostatic activity of the collagen particles from which the fiber is formed. The collagen fibers of the invention and hemostatic fabrics formed thereof optionally include hemostatic agents and/or other therapeutic agents, to further promote hemostasis and wound healing.Type: GrantFiled: December 11, 1998Date of Patent: March 26, 2002Assignee: C. R. Bard, Inc.Inventors: Robert D. Torgerson, John Uhoch, Francis B. Maddalo, Stephen N. Eldridge
-
Patent number: 5876421Abstract: A method for removing residual xylene from sutures includes contacting the suture with water either subjecting the suture to an atmosphere containing water vapor or be immersing the suture in liquid water, followed by drying the suture.Type: GrantFiled: March 25, 1997Date of Patent: March 2, 1999Inventors: Robert D. Torgerson, Ross R. Muth
-
Patent number: 5697976Abstract: A porous bioabsorbable surgical implant material is prepared by coating particles of bioabsorbable polymer with tissue ingrowth promoter. Typical bioabsorbable polymers include polymers of glycolide, lactide, caprolactone, trimethylene carbonate, dioxanone, and physical and chemical combinations thereof. The tissue ingrowth promoter can include calcium hydroxide and/or a hydrophilic coating material. The hydrophilic coating material can be bioabsorbable or non-bioabsorbable. A typical non-bioabsorbable hydrophilic coating material is polyhydroxyethyl methacrylate (PHEMA). The bioabsorbable implant material may also contain a therapeutic agent. Typical therapeutic agents include an antimicrobial agent, dye, growth factors and combinations thereof.Type: GrantFiled: September 14, 1994Date of Patent: December 16, 1997Assignee: United States Surgical CorporationInventors: Michael P. Chesterfield, Robert D. Torgerson
-
Patent number: 5658516Abstract: Flexible prosthetic implants for repairing, replacing or augmenting hard tissue or bone. The flexible implant comprises a plurality of segments that are connected by flexible retainers which enable the segments to be re-oriented in relation to one another to accommodate the contour, size and shape of the body part being treated. A method for making such flexible prosthetic implants is also disclosed.Type: GrantFiled: May 18, 1995Date of Patent: August 19, 1997Assignee: United States Surgical CorporationInventors: Barry Eppley, Thomas Sander, Robert D. Torgerson
-
Patent number: 5496371Abstract: Flexible prosthetic implants for repairing, replacing or augmenting hard tissue or bone. The flexible implant comprises a plurality of segments that are connected by flexible retainers which enable the segments to be re-oriented in relation to one another to accommodate the contour, size and shape of the body part being treated. A method for making such flexible prosthetic implants is also disclosed.Type: GrantFiled: June 1, 1993Date of Patent: March 5, 1996Assignee: United States Surgical CorporationInventors: Barry Eppley, Thomas Sander, Robert D. Torgerson
-
Patent number: 5366756Abstract: A porous bioabsorbable surgical implant material is prepared by coating particles of bioabsorbable polymer with a tissue ingrowth promoter. Typical polymers include polymers of glycolide, lactide, caprolactone, trimethylene carbonate, dioxanone and physical and chemical combinations thereof. The tissue ingrowth promoter can include calcium hydroxide and/or a hydrophillic coating material. The hydrophillic coating material can be bioabsorbable or non-bioabsorbable. A typical non-bioabsorbable hydrophillic coating material is polyhydroxymethylmethacrylate (PHEMA). The bioabsorbable implant material may also contain a therapeutic agent. Typical therapeutic agents include an antimicrobial agent, dye, growth factor and combinations thereof. Typically, the particles are prepared by rotary atomization and coated by spraying.Type: GrantFiled: June 15, 1992Date of Patent: November 22, 1994Assignee: United States Surgical CorporationInventors: Michael P. Chesterfield, Robert D. Torgerson
-
Patent number: 5037445Abstract: A vacuum bag method for in-situ molding of surgical implants. The method comprises creating an implant precursor material composed of an aggregation of polymer beads coated with a hydrophilic monomer dispersion. A flexible bag containing the implant precursor is molded in-situ to a desired specific shape, and the implant precursor is then rigidified by applying a vacuum to the interior of the bag. The implant precursor is cured by heating to form a unitary porous prosthesis which may be implanted into body tissue to remedy bone defects.Type: GrantFiled: April 14, 1989Date of Patent: August 6, 1991Assignee: United States Surgical CorporationInventors: Thomas Sander, Robert D. Torgerson